NextSteps Intervention for Advanced Cancer Patients and Caregivers
Primary Purpose
Lung Cancer, Gastrointestinal Cancer
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
NextSteps
Sponsored by
About this trial
This is an interventional supportive care trial for Lung Cancer
Eligibility Criteria
Inclusion Criteria:
- Patient has stage 3A, 3B, or 4 NSLC or extensive stage SCLC and is within one month of treatment initiation OR patient has Stage 4 GI cancer and is within one month of treatment initiation
- patient is spending more than 50% of time out of bed on a daily basis as measured by an ECOG Performance Status rating of level 0, 1, or 2
- patient has stable brain metastases and no limitation on hepatic or renal function
- patient has a spouse/partner other or close family member who he/she defines as the primary caregiver
- patient and caregiver are age 18 years or older
- patient and caregiver have the ability to read and understand English at a sixth grade level, as determined by ability to understand the consent form
- patient and caregiver can provide informed consent
Exclusion Criteria:
- patient or caregiver is deaf or has significant hearing impairment and thus cannot use the telephone
- patient is currently enrolled in hospice.
Sites / Locations
- Baylor College of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
NextSteps Intervention
Usual Medical Care
Arm Description
Patients and caregivers will each receive their own tailored manual and six weekly 45-minute telephone calls that correspond to the manual, delivered by a Masters level trained interventionist.
UMC consists of standard oncologic care for the patient from the point of diagnosis of advanced cancer.
Outcomes
Primary Outcome Measures
Patient and Caregiver Depression
Patient Reported Outcomes Measurement Information System Depression 6 item Short form
Patient and Caregiver Anxiety
Patient Reported Outcomes Measurement Information System Anxiety 6 item Short form
Secondary Outcome Measures
Patient and Caregiver Satisfaction with Care
20-item Family Satisfaction with Care (FAMCARE) scale
Patient Symptom Burden
M D Anderson Symptom Inventory
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04885439
Brief Title
NextSteps Intervention for Advanced Cancer Patients and Caregivers
Official Title
NextSteps: A Supportive Care Program For Advanced Cancer Patients and Their Caregivers
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
July 1, 2015 (Actual)
Primary Completion Date
December 1, 2020 (Actual)
Study Completion Date
June 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Baylor College of Medicine
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study seeks to test the efficacy of a psychosocial intervention to empower advanced cancer patients and their caregivers and improve their quality of life (QOL). The program, called NextSTEPS, provides skills training in six domains that are central to patient and caregiver QOL: self-care, stress management, symptom management, effective communication, problem-solving, and social support.
Detailed Description
In this study, 200 advanced cancer patients who are within one month of treatment initiation (baseline) and their caregivers will complete baseline surveys and be randomized to NextSTEPS or a usual medical care (UMC) condition. In addition to UMC, patients and caregivers in the NextSTEPS condition will each receive an intervention manual and six weekly 45-minute telephone counseling sessions with a trained interventionist. Patients and caregivers in both the NextSTEPS and UMC conditions will complete follow-up surveys at 8 weeks (2 months), 4 months, and 6 months post-baseline.
The specific aims are to:
Determine the impact of NextSTEPS on patient physical and emotional QOL, palliative care utilization, and satisfaction with care relative to UMC. We hypothesize that at 8 weeks (2 months), and 4 and 6 months, patients in NextSTEPS will have less symptom burden, less emotional distress, greater palliative care utilization, and greater satisfaction with care relative to patients in UMC.
Determine the impact of NextSTEPS on caregiver self-care, physical and emotional QOL, and satisfaction with care. We hypothesize that at 8 weeks, and 4 and 6 months, caregivers in NextSTEPS will report more self-care, better physical QOL, less emotional distress, and greater satisfaction with care relative to caregivers in UMC.
Secondary/exploratory aims and hypotheses are to:
Examine the effects of the NextSTEPS intervention on Self Determination Theory (SDT) constructs. We hypothesize that NextSTEPS will enhance patient and caregiver competence, autonomy, and relatedness.
Test whether the SDT constructs of competence, autonomy and relatedness mediate the effects of NextSTEPS on patient/caregiver outcomes as hypothesized.
Explore whether sociodemographic (e.g., age, gender), medical (e.g., disease stage, comorbidities), and relationship factors (e.g., whether the caregiver is a spouse/partner or other family member) moderate the effects of NextSTEPS on patient/caregiver competence, autonomy, and relatedness.
NextSTEPS fills an important service gap by providing education, skills training, and support to advanced cancer patients and their caregivers shortly after diagnosis. Home-based telephone delivery will facilitate dissemination and outreach. By empowering families with the skills they need to coordinate care and meet the challenges of advanced cancer together, NextSTEPS holds great promise for improving patient and caregiver QOL, and the quality of palliative and supportive care in cancer.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer, Gastrointestinal Cancer
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
242 (Actual)
8. Arms, Groups, and Interventions
Arm Title
NextSteps Intervention
Arm Type
Experimental
Arm Description
Patients and caregivers will each receive their own tailored manual and six weekly 45-minute telephone calls that correspond to the manual, delivered by a Masters level trained interventionist.
Arm Title
Usual Medical Care
Arm Type
No Intervention
Arm Description
UMC consists of standard oncologic care for the patient from the point of diagnosis of advanced cancer.
Intervention Type
Behavioral
Intervention Name(s)
NextSteps
Intervention Description
Intervention sessions are delivered by a Masters level trained interventionist. During sessions, the interventionist will: conduct the weekly symptom screen, review content, answer questions, ensure skills mastery through homework review, and work with participants to develop action plans and identify/overcome barriers to self-care/caregiving. Patients and caregivers will receive individual calls from the interventionist for sessions 1, 2, and 3, and participate together for sessions 4, 5, and 6 via speakerphone.
Primary Outcome Measure Information:
Title
Patient and Caregiver Depression
Description
Patient Reported Outcomes Measurement Information System Depression 6 item Short form
Time Frame
2 months
Title
Patient and Caregiver Anxiety
Description
Patient Reported Outcomes Measurement Information System Anxiety 6 item Short form
Time Frame
2 months
Secondary Outcome Measure Information:
Title
Patient and Caregiver Satisfaction with Care
Description
20-item Family Satisfaction with Care (FAMCARE) scale
Time Frame
2 months
Title
Patient Symptom Burden
Description
M D Anderson Symptom Inventory
Time Frame
2 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patient has stage 3A, 3B, or 4 NSLC or extensive stage SCLC and is within one month of treatment initiation OR patient has Stage 4 GI cancer and is within one month of treatment initiation
patient is spending more than 50% of time out of bed on a daily basis as measured by an ECOG Performance Status rating of level 0, 1, or 2
patient has stable brain metastases and no limitation on hepatic or renal function
patient has a spouse/partner other or close family member who he/she defines as the primary caregiver
patient and caregiver are age 18 years or older
patient and caregiver have the ability to read and understand English at a sixth grade level, as determined by ability to understand the consent form
patient and caregiver can provide informed consent
Exclusion Criteria:
patient or caregiver is deaf or has significant hearing impairment and thus cannot use the telephone
patient is currently enrolled in hospice.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hoda Badr, PhD
Organizational Affiliation
Baylor College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Baylor College of Medicine
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
12. IPD Sharing Statement
Learn more about this trial
NextSteps Intervention for Advanced Cancer Patients and Caregivers
We'll reach out to this number within 24 hrs